Ryder Steven 4

4 · REATA PHARMACEUTICALS INC · Filed Jul 12, 2022

Form 4

Period: 2022-07-11

Director

Transactions

Award
Class A common stock
2022-07-11$32.36/sh+3,794$122,774→ 8,878 total
Award
Stock Option (right-to-buy)
2022-07-11$22.36/sh+1,322$29,560→ 1,322 total
Exercise: $32.36Exp: 2032-07-11→ Class A common stock (1,322 underlying)
Award
Class A common stock
2022-07-11$32.36/sh+913$29,545→ 913 total
Award
Class A common stock
2022-07-11$32.36/sh+4,171$134,974→ 5,084 total
Award
Stock Option (right-to-buy)
2022-07-11+5,492→ 5,492 total
Exercise: $32.36Exp: 2032-07-11→ Class A common stock (5,492 underlying)
Award
Stock Option (right-to-buy)
2022-07-11+6,038→ 6,038 total
Exercise: $32.36Exp: 2032-07-11→ Class A common stock (6,038 underlying)

Footnotes (7)

[F1]The shares represent Restricted Stock Units (RSU), which vest on June 7, 2023, subject to continued service through the vesting date.
[F2]These RSU were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $29,545.00.
[F3]These shares represent RSU that vest in three equal yearly installments, subject to continued service through each vesting date.
[F4]These shares represent RSU that vest on June 7, 2023, subject to continued service through the vesting date.
[F5]The options vest in four equal installments on September 8, 2022, December 8, 2022, March 8, 2023, and June 7, 2023, subject to continued service through each vesting date.
[F6]These options were issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of director fees of $29,557.00.
[F7]The options vest in three equal yearly installments, subject to continued service through each vesting date.

Documents

1 file